![Warmest congratulations to PetCure Oncology!](https://img3.voofla.com/156/635/839362091566354.jpg)
05/15/2024
Warmest congratulations to PetCure Oncology!
Research.Discovery.Saving Lives.Finding Cures. The final phase of the study is currently in process.
(7)
Animal welfare organization with a focus on cancer research to benefit both pet companions and pediatric oncology patients. The Perseus Foundation provides financial assistance to pet owners who would otherwise not be able to treat, In Summer 2015 we formed a partnership with Aurelius Biotherapeutics to bring T Cell Therapy Infusion to dogs with B Cell Lymphoma.
Warmest congratulations to PetCure Oncology!
Friends, Don't miss this enlightening episode of the Veterinary Cancer Pioneers Podcast! 🎙️ Dr. Rachel Venable hosts the brilliant Dr. Chand Khanna, a luminary in veterinary and human oncology. Dive into the world of "communicative medicine" as Dr. Khanna shares his expertise garnered from a distinguished career. 🐾 Exciting updates on groundbreaking research at Ethos Discovery await, including insights from a nationwide clinical trial challenging the norms in splenic hemangiosarcoma treatment. 📈 Tune in to explore the potential revolution in canine cancer therapy!
In this insightful episode of the Veterinary Cancer Pioneers Podcast, Dr. Rachel Venable welcomes the esteemed Dr. Chand Khanna, founder and board chair of E...
Each year, March 13th is dedicated to National K9 Veterans Day — a day for recognizing and honoring the service and sacrifices of military and working dogs. It marks the official birthday of the United States K9 Corps, which was established back in 1942 for the first military dogs who served. 🐾❤️🐾
Through the MiliDog Fund, The Perseus Foundation helps defray the cost of cancer for our hero dogs.
Bellingham Veterinary in Bellingham, Washington provides free care for Retired Military Dogs and Retired Contract Dogs.
Our heartfelt gratitude for your incredible generosity, kindness and caring.
Bak's Legacy is the financial assistance fund within the MiliDog Program.
ACI Biosciences is currently enrolling dogs in a fully-funded clinical trial to assess an innovative, orally administered treatment for canine lymphoma, the first of its kind. Take this short survey to connect with a study team member (https://lnkd.in/euEVDx5Q) and learn more at https://lnkd.in/g6Yb3vh
🦮🐾
World, please help us by sharing. It promises to be a magical day and the sweetest of ways to honor Blaze!
Thank you 💚🐾❤️
We are just over one month away from the inaugural Blaze's Walk and are so excited to be partnering with ! Come out to Seneca Creek State Park on Sunday, April 7th, to help us honor Blaze, raise funds for the Perseus Foundation to help other canine lymphoma patients, and maybe even adopt a new furry friend!
Register here: https://www.wetravel.com/trips/blaze-s-walk-fundraiser-for-canine-lymphoma-blaze-adventure-tours-centennial-lake-maryland-14492389
This event is so much more than just a walk. There will be demos from dog trainers and veterinary experts, games, and more. Registration includes a t-shirt, lunch from , beer, and other swag. Don't forget to purchase some raffle tickets for the chance to win some super cool prizes! A photography session, dog training lesson, Baltimore or Annapolis harbor cruise tickets, and wine tastings, just to name a few.
We could not do this without our amazing sponsors. Thank you to , Apex Executive Search (.550), Zeynap & Otto,
Clinical trials are research studies that help Flint Animal Cancer Center at CSU VTH improve diagnostic tests and treatment options. Our clinical trials program enrolls client-owned pets to evaluate the effectiveness of new drugs, find novel uses of old drugs, or investigate new approaches to surgery and/or radiation therapy to treat cancer.
Many of the standard treatments used today are the result of clinical trials. We learn valuable information from every patient, and we use this information to improve their care as well as the care of future patients, both pets and people.
🐾 Neo's Journey: From Lymphoma Diagnosis to Cancer Survivor 🐾
We're proud to spotlight Neo, this week's Oncology Pet at Purdue Veterinary Medicine. Completing a rigorous 6-month CHOP chemotherapy protocol, Neo's resilience shines through. His family chose Purdue for its exceptional care, hoping to restore his vibrant spirit - a goal we've proudly achieved together.
Neo's story is a testament to love, determination, and the advanced oncological care available at Purdue. Let's celebrate Neo's health and happiness!
Meet Neo’s team at https://lnkd.in/gkpzwMi
Purdue University
Hi Friends 💙💚🤍
Let’s Celebrate and Honor Blaze by spreading the news!
What is Blaze's Walk Blaze's walk is both a fundraiser and a celebration of life in honor of Blaze and all the other dogs who have been lost to canine lymphoma. Our goal is to raise money for the Perseus Foundation in order to help provide costly life-saving treatment to dogs for bone marrow transpl...
So very happy to hear about Blue Pearl’s Initiative 💙🎈💙
BluePearl announces the launch of its charitable arm, BluePearl Cares, a nonprofit organization with a mission of making emergency and specialty veterinary care accessible for all.
🐾💙🎉Purdue University and its cross-disciplinary team is making strides in cancer research with a novel application of Doppler ultrasound to identify chemoresistance. This significant breakthrough could establish a new standard for personalized medicine, enhancing the precision of cancer treatment.
Learn how this technique, moving from phase-2 canine to human trials, demonstrates the potential of mechanical motion measurements in predicting chemotherapeutic outcomes: https://purdue.vet/3uwkMzF
Purdue University AVMA (American Veterinary Medical Association) American Animal Hospital Association American Animal Hospital Association Purdue Institute for Cancer Research
PetCure Oncology their approach to combating cancer in pets is rooted in the pursuit of a cure. They understand that the journey of cancer treatment encompasses a range of outcomes and results.
Factors Influencing Prognosis:
The effectiveness of SRS in treating cancer depends on multiple factors including:
Cancer type
Location
Stage
Their team assesses these elements to provide a tailored treatment plan, maximizing the potential for a positive outcome: shrinking tumors, slowing tumor growth or even achieving remission in some cases.
Regardless of the prognosis, Pet Cure Oncology’s focus remains steadfast on enhancing the quality of life for each and every pet. By combining advanced treatment with compassionate care, we aim to extend the lives of our furry patients while ensuring their comfort and well-being.
How Much Does SRS/SRT Cost?
The cost of treatment can vary significantly depending on whether the treatment is for palliative, conventional, or stereotactic radiation therapy (SRS/SRT).
• Palliative Radiation Therapy starts at about $3,500
• Conventional Radiation (CFRT) ranges from $7,500 - $13,500
• SRS/SRT protocols range from $9,000 - $12,000.
📱☎️📞PetCure Oncology | (833) VET-HERO |
Exciting News.
🐾❤️🐾 ACI Biosciences is currently enrolling dogs in a fully-funded clinical trial to assess an innovative, orally administered treatment for canine lymphoma, the first of its kind. Take this short survey to connect with a study team member (https://lnkd.in/euEVDx5Q) and learn more at https://lnkd.in/g6Yb3vhM
Cats get cancer, too! Unfortunately, when they do, it’s often very serious by the time of diagnosis. CSU is on a mission to improve outcomes for feline cancer. They have two new cat-specific clinical trials open. Join the fight against feline cancer – please help CSU spread the word!
Find open trials here: https://buff.ly/3GSNxbX
https://eliasanimalhealth.com/blog/can-we-treat-cancer-without-chemotherapy/
Cancer is the leading cause of death in dogs, and in humans it is second only to heart disease. For decades, chemotherapy has been the only option and a necessary evil to treat cancer. Most of us know someone who has gone through chemo, and
Just In🐾
New Immunotherapy Trial for Lymphoma from ELIAS Animal Health
Having focused on osteosarcoma in their just-completed trial, ELIAS Animal Health has announced a new trial for dogs with lymphoma.
ELIAS makes “personalized” vaccines for dog cancer that leverage your dog’s immune system to fight cancer. It’s a fascinating idea; you can learn more about it in this episode of DOG CANCER ANSWERS featuring CEO Tammie Wahaus.
The new trial, which will only have one location to start, will look at using their immunotherapy in combination with the VCAA chemo protocol. (That’s L-asparaginase, vincristine, cyclophosphamide, and doxorubicin.) Once dogs have received eight sessions of chemotherapy, they will be administered immunotherapy.
Then, they’ll be monitored for 18 months, after which time ELIAS will be able to compare them to a similar group of dogs (using historical data) who received only chemotherapy.
Will the immunotherapy extend remission? Survival times? They’ll know more in a couple of years!
Flint Animal Cancer Center at CSU . ❤️felt thanks for such awesome care! loves you Chloe❤️
Awesome News! Chloe was treated with radiation therapy for a histiocytic sarcoma tumor back in 2016. At the time, we weren’t sure how successful the treatment would be.
Chloe’s owners recently checked in. She’s now 15 and still living life to the fullest. She’s aging but has shown no signs of cancer returning.
She is the cutest and happiest dog and we’re so grateful to have received this update.
From the Flint Animal Cancer Center at CSU VTH.
Last month the first veterinary patient received an nfusion of CAR T cells as part of a clinical trial for treatment of bone cancer that has spread to the lungs.
CAR T cells are a form of immunotherapy that is used in people for a variety of cancer types. We are very excited to be able to use this in our patients and are hopeful that this will be an effective treatment for pets as well! Go, Gucci, go!
Thank you so much for your amazing contributions in treating our beloved animal buddies!❤️
Great opportunity to enlist a Veterinary Oncologist to wirk with your primary veterinarian!
https://petcancercareconsulting.com/about-us/
ACI Biosciences is currently enrolling dogs in a fully-funded clinical trial to assess an innovative, orally administered treatment for canine lymphoma, the first of its kind!
Purdue Veterinary Medicine is conducting a landmark clinical trial for dogs diagnosed with brain tumors, specifically meningioma or glioma. This trial not only aims to enhance treatment protocols but also offers a substantial financial incentive by providing free radiation treatment post-surgery, valued at over $7,000.
We invite you to visit https://purdue.vet/ctr-canine to explore the eligibility criteria and learn more about how your dog can contribute to this pioneering study.
American Animal Hospital Association (AAHA) Purdue Institute for Cancer Research Purdue University
The investigation clinically validated the OncoK9 test from PetDx, reinforcing previous study results.
Friends, Just wanted to share Dr. Clifford’s informative piece with you. 🐾
We would be remiss in not mentioning Bellingham Veterinary as they are the only private veterinary hospital in the country, including Veterinary Teaching Hospitals, to offer bone marrow transplantation for the treatment of canine lymphoma. They are truly pioneers in the field of BMT in dogs and have led the way.
If you are so inclined to do so take a peek at some of our adorable pet patients who beat the odds. Makes us so very happy!
https://drive.google.com/file/d/1Xi0JBKGaOVOvS_y5mxADzX3RXpVdpjYY/view?usp=drive_web
Canine lymphoma: new approaches to diagnostics and treatment
Dec 14, 2023
By Shannon Stolz, Senior Editor of Special Projects
“[Phenotyping] provides me information when I see the case and allows me to make more streamlined consult with the owners,” said Craig A. Clifford, DVM, MS, DACVIM (Oncology), at the recent Fetch dvm360 conference in Long Beach, California.1 As the veterinary industry shifts toward more individualized care approaches, canine lymphoma treatments and diagnostics are undergoing notable change. Because the different types of lymphoma have varying survivability rates and respond to treatment differently, the veterinary world is starting to put more focus on the initial prognosis.
Phenotyping
Prior to planning treatment for canine lymphoma, a crucial step is to determine which classification the patient falls into; around one third of dogs are considered to have T-cell lymphoma, while around two thirds are considered to have B-cell lymphoma, and
An open and wonderfully fun Invitation from Hotel Leo, a home away from home for pet parents who are traveling to Bellingham for Bone Marrow Transplantation at Bellingham Veterinary, Bellingham, Washington. You will receive an amazing discount at a very unique hotel. Please reach out to Brandon Lehmeyer, Complex General Manager
Hotel Leo | Heliotrope Hotel
Hotel Leo d 360.746.9097 | Heliotrope d 360.201.2914
o. office 360-935-4013
Letters to Santa!!! 🎄🎅🎄
Thursday & Saturdays in December
14 | 16 | 21 | 23
Santa! We know him! Stop by Hotel Leo on Thursday and Saturday nights in December to write a letter to Santa sip on complimentary hot cocoa and decorate an ornament. No matter if you have been naughty or nice Santa would love to hear from you. While the little ones write their letters we encourage parents to make their way to Amendment 21 for a special treat of their own – cocktail wine n/a beverages or a snack to share! All letters dropped off to Santa’s mailbox by December 23rd will receive a response from Santa himself!
Two decades ago, Dr. Chand Khanna, DVM, ACVIM Oncologist, proposed what might have seemed like a radical idea: creating a program at the National Institutes of Health to promote the study of naturally occurring cancer in dogs.
This year, the Comparative Oncology Program within the NCI Center for Cancer Research is celebrating its 20th anniversary. The program features the Comparative Oncology Trials Consortium, a network of academic centers in comparative oncology.
We are incredible honored and forever grateful that Dr. Khanna is Chairman Emeritus of The Perseus Foundation. His support has been incredible.
Shout out to Trupanion for assisting pet owners by covering T Cell Therapy! With a coverage of 90% reimbursement and immediate payment to clinics, it truly can make a difference as we choose treatments options for our BFF🐾❤️🐾
In this episode of Beyond the Clinic, you will be listening to the with acclaimed author and Diplomate, Renee Alsarraf DVM, DACVIM (Oncology), as she leads all animal owners through navigating a cancer diagnosis while debunking seven common myths about pet cancer along the way.
Information is powerful against the fight. If you are so inclined, please feel free to share by this episode of Beyond the Clinic with your every single pet owner you know.
In each episode of the VetSpecialists podcast, we invite Board-Certified Veterinary Specialists to sit down with us and discuss relevant topics in veterinary medicine and how they pertain to the general public of animal owners.
Exciting News 🐾
Merck Animal Health Announces Availability of Novel Canine Oncology Therapy to Veterinary Specialists Practicing Oncology Nationwide
Gilvetmab is Available to Veterinary Specialists Practicing Oncology to Treat Dogs with Mast Cell Tumors and Melanoma
RAHWAY, N.J., Oct. 13, 2023 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that its caninized monoclonal antibody gilvetmab (gil-VET-mab) is now available to veterinary specialists practicing oncology across the United States. Gilvetmab previously received conditional license approval for the treatment of dogs with mast cell tumors and for treatment of dogs with melanoma by the U.S. Department of Agriculture (USDA) Center for Veterinary Biologics (CVB).
Developed exclusively for therapeutic use in dogs, gilvetmab is a checkpoint inhibitor that specifically targets PD-1, reactivating the dog’s immune system to recognize and fight cancer cells. Mast cell tumor is one of the most common types of cancer in dogs comprising 20% of skin cancer cases1, and melanoma accounts for approximately 7% of all malignant tumors in dogs2. During initial trials, gilvetmab resulted in tumor shrinkage or maintenance of stable disease in 73% of dogs with mast cell tumor and 60% of dogs with melanoma over the course of the 20-week trial3.
“As an industry leader with vast research knowledge and scientific expertise in the immunotherapy field, we’re proud to announce the availability of gilvetmab to veterinary oncologists,” said Ian Tarpey, vice president, Research and Development, Merck Animal Health. “This new treatment adds a pioneering innovation to the field of veterinary oncology and elevates our extensive portfolio of veterinary medicines, vaccines, and technology solutions, further demonstrating our ongoing commitment to The Science of Healthier Animals.”
“At Merck Animal Health, we are committed to delivering technology, products and services that help improve the health and wellbeing of animals, including the beloved dogs in our homes,” said Laura Greene, DVM, DACVIM, senior professional services veterinarian and national internal medicine expert, Merck Animal Health. “With the availability of gilvetmab, a first-in-class monoclonal antibody, veterinary specialists practicing oncology now have a new option to treat dogs with mast cell tumor or melanoma. We look forward to working with the veterinary professionals who are pioneering the integration of this novel immunotherapy into their treatment plans.”
As Merck Animal Health enters the emerging field of canine oncology, gilvetmab will be administered by veterinary specialists practicing oncology. For clinics and veterinary professionals looking to learn more information about gilvetmab, please visit Merck Animal Health’s website.
In addition, the Gilvetmab Product Grant Program provides support to veterinary specialists practicing oncology seeking to better understand the role of Merck Animal Health’s conditionally licensed gilvetmab in various clinical scenarios. If you are interested in details on how to participate in ongoing clinical trials involving gilvetmab and dogs with stage III melanoma, please visit Melanoma Archives – Animal Clinical Investigation (animalci.com).
Peeking Out to remind you: Giving Tuesday is here🥰
https://drive.google.com/file/d/1kAYLHIrF7O645e-bUHfEZqkxOZcpMvlx/view?usp=drivesdk
From the amazing team at CSU Animal Cancer Center:
ne of the ways we’re fighting cancer and improving outcomes is through clinical trials.
Clinical trials are research studies that help us improve the detection and treatment of illnesses. Our clinical trials program enrolls client-owned pets to evaluate the effectiveness of new drugs, find novel uses of old drugs, or investigate new approaches to surgery and/or radiation therapy to treat cancer.
Many of the standard treatments used today are the result of clinical trials. Clinical trials are important because they –
- Contribute to research that discovers better treatments for pets and people with cancer;
- Provide an alternative when standard treatment options are no longer effective;
- Explore new therapies to treat disease that is unlikely to have a significant response to standard treatment;
- Offer financial assistance
As we bring awareness to pet cancer during National Pet Cancer Awareness Month, we want to spread the word about our clinical trials program. Not only could it mean your pet gets a novel treatment, but being in the study will also help future pets and people fight cancer in the future.
Nationwide
Washington D.C., DC
Be the first to know and let us send you an email when The Perseus Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to The Perseus Foundation:
Pups from all over the world are traveling to Bellingham in search of wellness. Every week there is a new arrival at Bellingham Veterinary who will be receiving a Bone Marrow Transplant. From a distance, #TeamPerseus is rooting for you! May your stories have the happiest of endings. Travel lightly and brightly. We love you!
We are beyond excited and delighted about our partnership with Hotel Leo, in Bellingham! As we have mentioned before, our goal is to create a hospitality house in Bellingham, Washington for pet clients and their humans to stay at while recovering from BMTs. A home away from home, if you will. Until that day, we are so happy and grateful to be able to have found such an amazing alternative to make your stay way as pleasant as we possibly can. Heartfelt thank you to Brandon, General Manager, Hotel Leo, for making this happen. We so appreciate you! Please reach out to us if you will be requiring accommodations. Bellingham Veterinary, Hotel Leo and The Perseus Foundation, in our respective roles, will do our very best to ensure the best possible stay.
#TeamPerseus is sending its warmest, happiest, and best wishes to our Bone Marrow Transplantation besties who are on the road to wellness. We hold you near and dear to our ❤️ and are rooting for a hugely successful outcome. Give us a shout if there is anything you need. 24/7. You’ve got this.
Happy Tuesday Friends! Many things are happening! We extend a warm invite for you to hop on board for a heartwarming experience. Consider volunteering with us in assisting to create a network for pet owners, that may be traveling to Bellingham Veterinary from many different states. #TeamBellingham is ready. #TeamPerseus is motivated to help in any way we are able to do so. These network will be crucial in finding ways that we can help pet owners setting up low cost overnight stays, a meal and a stopover or two for much needed rest. The Perseus Foundation is also looking for additional ways to assist, with hotel costs and transportation. World, we got this.
#TeamPerseus is going to share a heartwarming fact which not many know about Bellingham Veterinary. Bellingham Veterinary treats Retired Military Working Dogs with cancer and other life threatening conditions at little or no cost. Once these hero dogs are no longer active members of the military, there is no care provided by the government. It is up to people that adopt them, in many cases their handlers to care for them. After years of grueling working conditions, they deserve the very best care. In many cases, they develop cancer, which may be cost prohibitive. In collaboration with Bellingham Veterinary, The Perseus Foundation will ensure our heroes, thrive and enjoy their remaining years knowing full well that we are here for them. We will continue with indefatigable resource to raise funds for this program to thrive. An excerpt from an article published in 2015 by Andrew Romano. West Coast Correspondent. ""... But there was a difference: Baddy wasn't just any dog. He was a retired military dog, or MWD. As a member of the Marine Corps' HMX-1 canine squadron,Baddy had been responsible for safeguarding the presidential helicopter, Marine One, on roughly 200 domestic and international missions.... Trained to sniff for explosives and attack assailants, Baddy had spent eight years of his life protecting both President George W. Bush and President Barack Obama, and he had received the finest 24-hour veterinary care while doing it- at not cost to Hoffman or any of his other handlers... But as soon as Hoffman adopted Baddy, the government could not longer support him.”
Over 400 T Cell therapy infusions as we are approaching the target for study completion. Efficacy and Safety receiving the highest mark. So grateful to #TeamAurelius. Heartfelt gratitude to Dr. Kevin Steele for his outstanding contributions, indefatigable resolve and brilliance. We so appreciate you.
Wishing You a spectacular New Year filled with the realization of all your dreams, abundant health, warmth, love, endless joys, and magical surprises. 💫✨Always Reach For The ⭐️ ✨⭐️
T cell therapy refers to a type of cancer treatment that harnesses the power of the immune system to help in the combat against cancer. In the case of B cell lymphoma, immune cells are collected, selected, expanded and activated to ignite an immune attack on the cancer cells. Recruiting the patients’ own T cells to attack the tumor is a revolutionary approach to combat lymphoma.
Giving Tuesday is fast approaching! Let’s donate to our favorite cause(s). Internal bleeding, most commonly from cancer, is a common reason older dogs, particularly German Shepherd type breeds, need a blood transfusion. Interested in having your pet become a donor in saving lives? If you are in the Bellingham, Washington area, please reach out to Brittany at Northwest Veterinary Blood Bank. Donation Site: Bellingham Veterinary, Bellingham, Washington at 360.734.0720. Please feel free to share. Thank you!
Tomorrow. Let's all get ready for Giving Tuesday! #TeamPerseus is ready and excited about Giving Tuesday and the endless possibilities for charities who need a helping hand! And don't forget the kindest of gestures, can put a smile in someone's heart. Our last post this evening, we will share news of a wonderful promotion that will benefit The Perseus Foundation. Just readying the announcement. We will not disappoint. Stay tuned!
November Pet Cancer Awareness bring news of an exciting and unique initiative for our foundation. We are very happy to announce that The Perseus Foundation is launching a talkline in 2023! We would love for you to provide your ideas and suggestions as to what type of information you would like us to provide to best serve you. More details to follow, as well as volunteer opportunities!
Our team tries to come up with all sorts of ideas, fun ones, little ones and big ones. Information, scientific discovery, providing financial assistance will always be on the forefront. Having said this, there is so much more we want to accomplish. And we shall. 2023 will bring yet a new initiative to our mission. In so doing, we need a little help. 🐾♥️🐾
2022 is bringing us closer to the completion of Aurelius Biotherapeutics T Cell Adoptive Immunotherapy Study.  Heartfelt gratitude to the Pioneer Hero Pups and their humans. You reign supreme in our ♥️’s. We could not have gotten as far as we have without your trust, vision and indefatigable resolve in your pursuit of a promising future where we slay the dragon.
What is T Cell Therapy? Cells from the patient’s own immune system, T Lymphocytes are collected, cultured and activated to be tumor-cell specific. Once their numbers are maximally expanded, they are infused back in to the patient. By recruiting the immune system we hope to provide another way to fight the cancer cells.🐾
#fridayfeels Are you feeling you may want to learn a little bit more about immunotherapy? Here you go!
So excited! We seriously can’t wait to hear the update about Koda’s receiving his first T Cell Adoptive Immunotherapy treatment tomorrow. Let’s send Koda our very best wishes for a hugely successful treatment. Go T Cellls Go!!!
Animal comparative non profit with a focus on cancer research to benefit both pet companions and pediatric oncology patients. The Perseus Foundation provides financial assistance to pet owners who would otherwise not be able to treat, In Summer 2015 we formed a partnership with Aurelius Biotherapeutics to bring T Cell Therapy Infusion to dogs with B Cell Lymphoma. The first phase of the study is currently in process. The Teddy Bear Fund helps defray the cost of cancer care in cats. Our newest fund, The MiliDog Fund provides financial assistance for cancer care to our RWDs and CWDs. The Perseus Magic Fund, provides financial support for canine cancer patients enrolled in clinical trials, T Cell Therapy for B Cell lymphoma and Bone Marrow Transplants in dogs and SRS.
Friendship Hospital for Animals
Brandywine Street NWAmerican Veterinary Medical Association Congr
Sunderland Place NW